Under construction – not a live service
Sign in
Taking people in MexicoNo phase

Registry of Outcomes of Dezawa MuseCells®

Key facts

Where
Guadalajara, MexicoSee the site

Where in Mexico

  • Regene LabsGuadalajara, MexicoContact: Regene LabsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
MuseCell Innovations Pte LTD
Trial code
NCT07645989
Record updated
12 June 2026
Original description
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.Read full original descriptionShow less

The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases.

The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.

Inclusion: Received Dezawa MuseCells® as Part of Routine Clinical Care; Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up; Willingness to Complete Online Survey Assessments; Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period; Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions; Ability to Communicate in the Registry's Supported Language; Participants must be able to read and respond to registry surveys in the designated study language; Enrollment Within 12 Months of MuseCell® Administration.

Exclusion: Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included; Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes; Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf; History of Malignancy Diagnosed Within the Past 12 Months; Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns; Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality; Inability to Participate in Long-Term Digital Follow-Up; Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods; Pregnant or Actively Breastfeeding at Time of Enrollment.

ClinicalTrials.gov NCT07645989